Atossa Therapeutics leading clinical trial that may improve pulmonary function in COVID-19 patients

Apr. 6, 2020 - 04:27 - Dr. Steven Quay, physician scientist and Atossa Therapeutics CEO, joins 'America's Newsroom' to explain.